Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 

Health Service Policy

Radiotherapy gets the investment it needs

NHS England has announced that it will invest £130m in new radiotherapy machines. Read why that investment is so important.

Cancer waiting times: what’s causing the delays?

A key cancer waiting time target has been missed again in England, we investigate why.

More people are getting cancer, but what do the numbers really mean?

New figures we’ve released today estimate that by the year 2035, half a million people could be diagnosed with cancer each year in the UK.

Our Local Cancer Statistics website – three years on

We explore how local data is shaping cancer services in your area.

Improving care for cancer patients in Northern Ireland

Our new report looking at cancer care in Northern Ireland uncovers some key areas for improvement.

New data on cancer treatment to help improve care

Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England.

All women with ovarian cancer should be offered genetic testing – so why aren’t they?

Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why.

Are patients being told about opportunities to take part in research?

We see if all patients had equal opportunity to take part in cancer research.

NICE kicks off 'new approach' with leukaemia drug approval

A drug previously considered too expensive for the NHS will now become widely available after NICE agreed a discount

Prostate cancer trial results should mean fewer hospital trips to have radiotherapy

The results of a clinical trial testing radiotherapy doses for treating prostate cancer should be good news for men.